Long-chain polyunsaturated fatty acids (LCPUFA) from genesis to senescence: the influence of LCPUFA on neural development, aging, and neurodegeneration.

Many clinical and animal studies demonstrate the importance of long-chain polyunsaturated fatty acids (LCPUFA) in neural development and neurodegeneration. This review will focus on involvement of LCPUFA from genesis to senescence. The LCPUFA docosahexaenoic acid and arachidonic acid are important components of neuronal membranes, while eicosapentaenoic acid, docosahexaenoic acid, and arachidonic acid also affect cardiovascular health and inflammation. In neural development, LCPUFA deficiency can lead to severe disorders like schizophrenia and attention deficit hyperactivity disorder. Perinatal LCPUFA supplementation demonstrated beneficial effects in neural development in humans and rodents resulting in improved cognition and sensorimotor integration. In normal aging, the effect of LCPUFA on prevention of cognitive impairment will be discussed. LCPUFA are important for neuronal membrane integrity and function, and also contribute in prevention of brain hypoperfusion. Cerebral perfusion can be compromised as result of obesity, cerebrovascular disease, hypertension, or diabetes mellitus type 2. Last, we will focus on the role of LCPUFA in most common neurodegenerative diseases like Alzheimer's disease and Parkinson's disease. These disorders are characterized by impaired cognition and connectivity and both clinical and animal supplementation studies have shown the potential of LCPUFA to decrease neurodegeneration and inflammation. This review shows that LCPUFA are essential throughout life.

[1]  N. Meguid,et al.  Role of polyunsaturated fatty acids in the management of Egyptian children with autism. , 2008, Clinical biochemistry.

[2]  A. Richardson.  Omega-3 fatty acids in ADHD and related neurodevelopmental disorders , 2006, International review of psychiatry.

[3]  A. Verma,et al.  Mediterranean Diet and Risk for Alzheimer's Disease , 2008 .

[4]  M. Hadders‐Algra,et al.  The Groningen LCPUFA study: no effect of postnatal long-chain polyunsaturated fatty acids in healthy term infants on neurological condition at 9 years. , 2010, The British journal of nutrition.

[5]  J. Van Aerde,et al.  Feeding preterm infants a formula containing C20 and C22 fatty acids simulates plasma phospholipid fatty acid composition of infants fed human milk. , 1992, Early human development.

[6]  B. Strandvik,et al.  EPA supplementation improves teacher rated behaviour and oppositional symptoms in children with ADHD Short title : RCT of EPA in ADHD , 2011 .

[7]  Bill X. Huang,et al.  Effects of docosahexaenoic acid on mouse brain synaptic plasma membrane proteome analyzed by mass spectrometry and (16)O/(18)O labeling. , 2011, Journal of proteome research.

[8]  M. Hadders‐Algra,et al.  Supplementation of DHA but not DHA with arachidonic acid during pregnancy and lactation influences general movement quality in 12-week-old term infants. , 2010, The British journal of nutrition.

[9]  A. Lucas,et al.  Randomized, double-blind trial of long-chain polyunsaturated fatty acid supplementation with fish oil and borage oil in preterm infants. , 2004, The Journal of pediatrics.

[10]  G. Billman,et al.  Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. , 2003, Circulation.

[11]  E. Glasgow,et al.  Quartan malarial nephrotic syndrome. Collaborative clinicopathological study in Nigerian children. , 1972, Lancet.

[12]  J. Janowsky,et al.  Formula Supplementation With Long-chain Polyunsaturated Fatty Acids: Are There Developmental Benefits? , 1998, Pediatrics.

[13]  S. Chalon.  The role of fatty acids in the treatment of ADHD , 2009, Neuropharmacology.

[14]  R. Voigt,et al.  Effects of maternal docosahexaenoic acid intake on visual function and neurodevelopment in breastfed term infants. , 2005, The American journal of clinical nutrition.

[15]  Frank M LaFerla,et al.  Dietary Docosahexaenoic Acid and Docosapentaenoic Acid Ameliorate Amyloid-β and Tau Pathology via a Mechanism Involving Presenilin 1 Levels , 2007, The Journal of Neuroscience.

[16]  P. Willatts,et al.  Effects of long-chain PUFA supplementation in infant formula on cognitive function in later childhood , 2013 .

[17]  F. Calon,et al.  Docosahexaenoic Acid-Derived Neuroprotectin D1 Induces Neuronal Survival via Secretase- and PPARγ-Mediated Mechanisms in Alzheimer's Disease Models , 2011, PloS one.

[18]  G. Michael,et al.  Omega‐3 fatty acids reverse age‐related decreases in nuclear receptors and increase neurogenesis in old rats , 2010, Journal of neuroscience research.

[19]  T. Cai,et al.  n-3 polyunsaturated fatty acids inhibit lipopolysaccharide-induced microglial activation and dopaminergic injury in rats. , 2012, Neurotoxicology.

[20]  C.P.G.M. de Groot,et al.  Effect of fish oil supplementation on cognitive performance in older subjects: a randomized, double-blind, placebo-controlled trial , 2008 .

[21]  W. Connor,et al.  Importance of n-3 fatty acids in health and disease. , 2000, The American journal of clinical nutrition.

[22]  F. LaFerla,et al.  Role of calcium in the pathogenesis of Alzheimer's disease and transgenic models. , 2007, Sub-cellular biochemistry.

[23]  R. Birk,et al.  Docosahexaenoic Acid Significantly Stimulates Immediate Early Response Genes and Neurite Outgrowth , 2009, Neurochemical Research.

[24]  P. Scheltens,et al.  Efficacy of a medical food on cognition in Alzheimer’s Disease: Results from secondary analyses of a randomized, controlled trial , 2011, The journal of nutrition, health & aging.

[25]  E. Levy,et al.  Omega-3 fatty acid treatment of children with attention-deficit hyperactivity disorder: A randomized, double-blind, placebo-controlled study. , 2009, Paediatrics & child health.

[26]  O. Hernell,et al.  Effect of formula supplemented with docosahexaenoic acid and gamma-linolenic acid on fatty acid status and visual acuity in term infants. , 1998, Journal of pediatric gastroenterology and nutrition.

[27]  J. Buckley,et al.  Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: a 6-month randomised controlled trial , 2011, British Journal of Nutrition.

[28]  Y. Kiso.  Pharmacology in health foods: effects of arachidonic acid and docosahexaenoic acid on the age-related decline in brain and cardiovascular system function. , 2011, Journal of pharmacological sciences.

[29]  O. Harel,et al.  Maternal consumption of a docosahexaenoic acid-containing functional food during pregnancy: benefit for infant performance on problem-solving but not on recognition memory tasks at age 9 mo. , 2007, The American journal of clinical nutrition.

[30]  R. Uauy,et al.  Lipid needs of preterm infants: updated recommendations. , 2013, The Journal of pediatrics.

[31]  J. Stamler,et al.  Relation of long chain n-3 polyunsaturated fatty acid intake to serum high density lipoprotein cholesterol among Japanese men in Japan and Japanese-American men in Hawaii: the INTERLIPID study. , 2005, Atherosclerosis.

[32]  F. Cicchetti,et al.  Modulation of brain-derived neurotrophic factor as a potential neuroprotective mechanism of action of omega-3 fatty acids in a parkinsonian animal model , 2009, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[33]  C. Tanner,et al.  Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030 , 2007, Neurology.

[34]  H M Sinclair,et al.  The composition of the Eskimo food in north western Greenland. , 1980, The American journal of clinical nutrition.

[35]  N. Salem,et al.  An n-3 fatty acid deficiency impairs rat spatial learning in the Barnes maze. , 2009, Behavioral neuroscience.

[36]  N. Salem,et al.  Omega-3 fatty acids and rodent behavior. , 2006, Prostaglandins, leukotrienes, and essential fatty acids.

[37]  I. Skoog,et al.  Update on hypertension and Alzheimer's disease , 2006, Neurological research.

[38]  Alberto Pilotto,et al.  Nutraceutical properties of Mediterranean diet and cognitive decline: possible underlying mechanisms. , 2010, Journal of Alzheimer's disease : JAD.

[39]  K. Michaelsen,et al.  Maternal fish oil supplementation in lactation: effect on developmental outcome in breast-fed infants. , 2005, Reproduction, nutrition, development.

[40]  J. Palmblad,et al.  Omega‐3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms , 2008, International journal of geriatric psychiatry.

[41]  Kristin Saarem,et al.  Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age. , 2003, Pediatrics.

[42]  P. Dederen,et al.  Impact of a multi-nutrient diet on cognition, brain metabolism, hemodynamics, and plasticity in apoE4 carrier and apoE knockout mice , 2013, Brain Structure and Function.

[43]  Michio Hashimoto,et al.  DOCOSAHEXAENOIC ACID‐INDUCED PROTECTIVE EFFECT AGAINST IMPAIRED LEARNING IN AMYLOID β‐INFUSED RATS IS ASSOCIATED WITH INCREASED SYNAPTOSOMAL MEMBRANE FLUIDITY , 2006, Clinical and experimental pharmacology & physiology.

[44]  M. Bornstein,et al.  Growth and development in term infants fed long-chain polyunsaturated fatty acids: a double-masked, randomized, parallel, prospective, multivariate study. , 2001, Pediatrics.

[45]  J. Dyerberg,et al.  The composition of food consumed by Greenland Eskimos. , 2009, Acta medica Scandinavica.

[46]  N. Salem,et al.  Deficit of Prepulse Inhibition in Mice Caused by Dietary n‐3 Fatty Acid Deficiencies. , 2008, Behavioral neuroscience.

[47]  Lawrence J Appel,et al.  Omega-3 Fatty Acids and Cardiovascular Disease: New Recommendations From the American Heart Association , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[48]  P. Steenhout,et al.  Improved growth of toddlers fed a milk containing synbiotics. , 2011, Asia Pacific journal of clinical nutrition.

[49]  L. Grégoire,et al.  Nur77 mRNA levels and L-Dopa-induced dyskinesias in MPTP monkeys treated with docosahexaenoic acid , 2009, Neurobiology of Disease.

[50]  Katrina Jane Williams,et al.  Omega-3 fatty acids supplementation for autism spectrum disorders (ASD). , 2011, The Cochrane database of systematic reviews.

[51]  S. Innis,et al.  Essential n-3 fatty acids in pregnant women and early visual acuity maturation in term infants. , 2008, The American journal of clinical nutrition.

[52]  J. Dyerberg,et al.  Plasma Lipid and Lipoprotein Pattern in Greenlandic West-Coast Eskimos , 2009 .

[53]  W. Gordon,et al.  Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer's, and other neurodegenerative diseases. , 2011, Annual review of nutrition.

[54]  R. Kalaria,et al.  Vascular basis for brain degeneration: faltering controls and risk factors for dementia. , 2010, Nutrition reviews.

[55]  M. Hadders‐Algra,et al.  The influence of supplemental docosahexaenoic and arachidonic acids during pregnancy and lactation on neurodevelopment at eighteen months. , 2011, Prostaglandins, leukotrienes, and essential fatty acids.

[56]  S. Innis.  Dietary omega 3 fatty acids and the developing brain , 2008, Brain Research.

[57]  Michael Weiner,et al.  Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. , 2010, JAMA.

[58]  L. Ferrucci,et al.  Carotid Atherosclerosis and Prospective Risk of Dementia , 2012, Stroke.

[59]  R. Gibson,et al.  Conversion of linoleic acid and alpha-linolenic acid to long-chain polyunsaturated fatty acids (LCPUFAs), with a focus on pregnancy, lactation and the first 2 years of life. , 2011, Maternal & child nutrition.

[60]  G. Cole,et al.  Neuroprotective action of omega-3 polyunsaturated fatty acids against neurodegenerative diseases: evidence from animal studies. , 2007, Prostaglandins, leukotrienes, and essential fatty acids.

[61]  R. Akinyemi,et al.  Does vascular pathology contribute to Alzheimer changes? , 2012, Journal of the Neurological Sciences.

[62]  A. Schapira,et al.  Genetic and environmental factors in the cause of Parkinson's disease , 2003, Annals of neurology.

[63]  Cornelis J Stam,et al.  Efficacy of Souvenaid in mild Alzheimer's disease: results from a randomized, controlled trial. , 2012, Journal of Alzheimer's disease : JAD.

[64]  D. Head,et al.  Selective aging of the human cerebral cortex observed in vivo: differential vulnerability of the prefrontal gray matter. , 1997, Cerebral cortex.

[65]  H. Tanila,et al.  Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP/PS1 transgenic mice , 2006, Neurobiology of Disease.

[66]  Takashi Morihara,et al.  Dietary n‐3 polyunsaturated fatty acid depletion activates caspases and decreases NMDA receptors in the brain of a transgenic mouse model of Alzheimer's disease , 2005, The European journal of neuroscience.

[67]  N. Tandon.  Neurosurgery at an earlier stage of Parkinson disease: A randomized, controlled trial , 2008 .

[68]  E. Elvevoll,et al.  Health benefits of marine foods and ingredients. , 2011, Biotechnology advances.

[69]  Anthony Windust,et al.  Omega-3 fatty acids, energy substrates, and brain function during aging. , 2006, Prostaglandins, leukotrienes, and essential fatty acids.

[70]  E. Beltrão,et al.  Differential vulnerability of substantia nigra and corpus striatum to oxidative insult induced by reduced dietary levels of essential fatty acids , 2012, Front. Hum. Neurosci..

[71]  Anthony H V Schapira,et al.  Timing of Deep Brain Stimulation in Parkinson Disease: A Need for Reappraisal? , 2013, Annals of neurology.

[72]  R. Wurtman,et al.  Use of phosphatide precursors to promote synaptogenesis. , 2009, Annual review of nutrition.

[73]  G. Jicha,et al.  Omega-3 fatty acids: potential role in the management of early Alzheimer’s disease , 2010, Clinical interventions in aging.

[74]  P. Rhodes,et al.  Long-Term Feeding of Formulas High in Linolenic Acid and Marine Oil to Very Low Birth Weight Infants: Phospholipid Fatty Acids , 1991, Pediatric Research.

[75]  Yogesh K. Dwivedi,et al.  Adult Medication-Free Schizophrenic Patients Exhibit Long-Chain Omega-3 Fatty Acid Deficiency: Implications for Cardiovascular Disease Risk , 2013, Cardiovascular psychiatry and neurology.

[76]  T. Nettelbeck,et al.  The older people, omega-3, and cognitive health (EPOCH) trial design and methodology: A randomised, double-blind, controlled trial investigating the effect of long-chain omega-3 fatty acids on cognitive ageing and wellbeing in cognitively healthy older adults , 2011, Nutrition journal.

[77]  Jan K Buitelaar,et al.  Internal and external validity of Attention-Deficit Hyperactivity Disorder in a population-based sample of adults , 2004, Psychological Medicine.

[78]  Cai Song,et al.  Cognitive enhancement by omega-3 fatty acids from child-hood to old age: Findings from animal and clinical studies , 2013, Neuropharmacology.

[79]  R. Demir,et al.  The influence and the mechanism of docosahexaenoic acid on a mouse model of Parkinson’s disease , 2011, Neurochemistry International.

[80]  R. Agrawal,et al.  ‘Metabolic syndrome’ in the brain: deficiency in omega‐3 fatty acid exacerbates dysfunctions in insulin receptor signalling and cognition , 2012, The Journal of physiology.

[81]  A. Dyer,et al.  Accumulated Evidence on Fish Consumption and Coronary Heart Disease Mortality: A Meta-Analysis of Cohort Studies , 2004, Circulation.

[82]  M. Hadders‐Algra.  Prenatal and early postnatal supplementation with long-chain polyunsaturated fatty acids: neurodevelopmental considerations. , 2011, The American journal of clinical nutrition.

[83]  F. Gomez-Pinilla,et al.  Docosahexaenoic acid dietary supplementation enhances the effects of exercise on synaptic plasticity and cognition , 2008, Neuroscience.

[84]  B. Zlokovic,et al.  The cerebromicrovasculature: a key player in the pathogenesis of Alzheimer's disease. , 2002, Journal of Alzheimer's disease : JAD.

[85]  Hsi-Kung Kuo,et al.  The effect of supplementation of docosahexaenoic acid and arachidonic acid on visual acuity and neurodevelopment in larger preterm infants. , 2005, Chang Gung medical journal.

[86]  E. Birch,et al.  Visual function in breast-fed term infants weaned to formula with or without long-chain polyunsaturates at 4 to 6 months: a randomized clinical trial. , 2003, The Journal of pediatrics.

[87]  H. Tanila,et al.  Changes in cerebral blood volume and amyloid pathology in aged Alzheimer APP/PS1 mice on a docosahexaenoic acid (DHA) diet or cholesterol enriched Typical Western Diet (TWD) , 2007, Neurobiology of Disease.

[88]  J. C. de la Torre.  A turning point for Alzheimer's disease? , 2012, BioFactors.

[89]  C. Agostoni.  Role of Long-chain Polyunsaturated Fatty Acids in the First Year of Life , 2008, Journal of pediatric gastroenterology and nutrition.

[90]  P. Dederen,et al.  DHA and cholesterol containing diets influence Alzheimer-like pathology, cognition and cerebral vasculature in APPswe/PS1dE9 mice , 2009, Neurobiology of Disease.

[91]  R. Shah.  Medical Foods for Alzheimer’s Disease , 2011, Drugs & aging.

[92]  A. Michael-Titus,et al.  Neurological Benefits of Omega-3 Fatty Acids , 2008, NeuroMolecular Medicine.

[93]  H. Okuyama,et al.  Regional differences of the mouse brain in response to an α-linolenic acid-restricted diet: Neurotrophin content and protein kinase activity. , 2010, Life sciences.

[94]  C. Gillberg,et al.  Omega-3/Omega-6 Fatty Acids for Attention Deficit Hyperactivity Disorder , 2009, Journal of attention disorders.

[95]  P. Iversen,et al.  Improved Cognitive Development Among Preterm Infants Attributable to Early Supplementation of Human Milk With Docosahexaenoic Acid and Arachidonic Acid , 2008, Pediatrics.

[96]  G. Hacioglu,et al.  Docosahexaenoic acid provides protective mechanism in bilaterally MPTP-lesioned rat model of Parkinson's disease. , 2012, Folia histochemica et cytobiologica.

[97]  A. Leong.  Diet, Nutrition, and the Prevention of Chronic Diseases , 1992 .

[98]  D. Mostofsky,et al.  Essential fatty acids preparation (SR-3) improves Alzheimer's patients quality of life. , 1996, The International journal of neuroscience.

[99]  P. Calder,et al.  Omega-3 (n-3) fatty acids, cardiovascular disease and stability of atherosclerotic plaques. , 2010, Cellular and molecular biology.

[100]  H. Cena,et al.  Behavioral effects of omega-3 fatty acid supplementation in young adults with severe autism: an open label study. , 2008, Archives of medical research.

[101]  C. Blanco,et al.  Long-chain polyene status of preterm infants with regard to the fatty acid composition of their diet: Comparison between absolute and relative fatty acid levels in plasma and erythrocyte phospholipids , 1995, British Journal of Nutrition.

[102]  A. Rubino,et al.  Comment on the Content and Composition of Lipids in Infant Formulas , 1991, Acta paediatrica Scandinavica.

[103]  S. Chalon.  Omega-3 fatty acids and monoamine neurotransmission. , 2006, Prostaglandins, leukotrienes, and essential fatty acids.

[104]  O. Harel,et al.  A Docosahexaenoic Acid-Functional Food During Pregnancy Benefits Infant Visual Acuity at Four but not Six Months of Age , 2007, Lipids.

[105]  M. de Lorgeril,et al.  Cretan Mediterranean diet for prevention of coronary heart disease. , 1995, The American journal of clinical nutrition.

[106]  M. Hadders‐Algra.  The role of long-chain polyunsaturated fatty acids (LCPUFA) in growth and development. , 2005, Advances in experimental medicine and biology.

[107]  M. Leach,et al.  Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents. , 2012, The Cochrane database of systematic reviews.

[108]  J. leCoutre,et al.  Pathophysiology and Evolutionary Aspects of Dietary Fats and Long-Chain Polyunsaturated Fatty Acids across the Life Cycle -- Fat Detection: Taste, Texture, and Post Ingestive Effects , 2010 .

[109]  P. Ashwood,et al.  A Pilot Randomized Controlled Trial of Omega-3 Fatty Acids for Autism Spectrum Disorder , 2010, Journal of autism and developmental disorders.

[110]  E. Birch,et al.  Visual acuity and cognitive outcomes at 4 years of age in a double-blind, randomized trial of long-chain polyunsaturated fatty acid-supplemented infant formula. , 2007, Early human development.

[111]  K. Hird,et al.  Achieving definitive results in long-chain polyunsaturated fatty acid supplementation trials of term infants: factors for consideration. , 2011, Nutrition reviews.

[112]  F. Sofi,et al.  The atherosclerotic risk profile is affected differently by fish flesh with a similar EPA and DHA content but different n-6/n-3 ratio. , 2013, Asia Pacific journal of clinical nutrition.

[113]  W. Harris,et al.  Influence of n-3 fatty acid supplementation on the endogenous activities of plasma lipases. , 1997, The American journal of clinical nutrition.

[114]  E. Isaacs,et al.  Double-blind, randomized trial of long-chain polyunsaturated fatty acid supplementation in formula fed to preterm infants. , 2002, Pediatrics.

[115]  P. Couvreur,et al.  Polyunsaturated fatty acids (PUFA) and eicosanoids in human health and pathologies. , 2002, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[116]  U. Das.  Folic acid and polyunsaturated fatty acids improve cognitive function and prevent depression, dementia, and Alzheimer's disease--but how and why? , 2008, Prostaglandins, leukotrienes, and essential fatty acids.

[117]  E. Isaacs,et al.  10-year Cognition in Preterms After Random Assignment to Fatty Acid Supplementation in Infancy , 2011, Pediatrics.

[118]  A. Hofman,et al.  Blood Pressure and Risk of Dementia: Results from the Rotterdam Study and the Gothenburg H-70 Study , 2000, Dementia and Geriatric Cognitive Disorders.

[119]  S. Innis,et al.  Genetic variants of the FADS1 FADS2 gene cluster are associated with altered (n-6) and (n-3) essential fatty acids in plasma and erythrocyte phospholipids in women during pregnancy and in breast milk during lactation. , 2008, The Journal of nutrition.

[120]  Mikael Fogelholm,et al.  Faculty of 1000 evaluation for Primary prevention of cardiovascular disease with a Mediterranean diet. , 2013 .

[121]  E. Ermilov,et al.  Omega-3 fatty acids: benefits for cardio-cerebro-vascular diseases. , 2012, Atherosclerosis.

[122]  S. Estrada-Mondaca,et al.  Fatty Acids and Neurodevelopment , 2008, Journal of pediatric gastroenterology and nutrition.

[123]  H. Okuyama,et al.  Reversibility of n-3 fatty acid deficiency-induced alterations of learning behavior in the rat: level of n-6 fatty acids as another critical factor. , 2001, Journal of lipid research.

[124]  Lucia Kerti,et al.  Long-chain omega-3 fatty acids improve brain function and structure in older adults. , 2014, Cerebral cortex.

[125]  Lars Smith,et al.  Attention among very low birth weight infants following early supplementation with docosahexaenoic and arachidonic acid , 2011, Acta paediatrica.

[126]  P. Libby,et al.  Immune effector mechanisms implicated in atherosclerosis: from mice to humans. , 2013, Immunity.

[127]  G. Cole,et al.  Omega-3 fatty acids and dementia. , 2009, Prostaglandins, leukotrienes, and essential fatty acids.

[128]  E. P. Kennedy,et al.  The function of cytidine coenzymes in the biosynthesis of phospholipides. , 1956, The Journal of biological chemistry.

[129]  D. Salat,et al.  Prefrontal gray and white matter volumes in healthy aging and Alzheimer disease. , 1999, Archives of neurology.

[130]  E. Hjorth,et al.  Immunomodulation of microglia by docosahexaenoic acid and eicosapentaenoic acid , 2012, Current opinion in clinical nutrition and metabolic care.

[131]  F. Muskiet.  Pathophysiology and Evolutionary Aspects of Dietary Fats and Long-Chain Polyunsaturated Fatty Acids across the Life Cycle , 2010 .

[132]  J. Dyerberg,et al.  Lipid metabolism, atherogenesis, and haemostasis in Eskimos: the role of the prostaglandin-3 family. , 1979, Haemostasis.

[133]  M. Hadders‐Algra,et al.  Neurologic Condition of Healthy Term Infants at 18 Months: Positive Association With Venous Umbilical DHA Status and Negative Association With Umbilical Trans-fatty Acids , 2006, Pediatric Research.

[134]  J. Janowsky,et al.  Visual, cognitive, and language assessments at 39 months: a follow-up study of children fed formulas containing long-chain polyunsaturated fatty acids to 1 year of age. , 2003, Pediatrics.

[135]  Artemis P. Simopoulos,et al.  Evolutionary Aspects of Diet: The Omega-6/Omega-3 Ratio and the Brain , 2011, Molecular Neurobiology.

[136]  S. Carlson.  Arachidonic acid status of human infants: influence of gestational age at birth and diets with very long chain n-3 and n-6 fatty acids. , 1996, The Journal of nutrition.

[137]  R. Raz,et al.  The influence of short-chain essential fatty acids on children with attention-deficit/hyperactivity disorder: a double-blind placebo-controlled study. , 2009, Journal of child and adolescent psychopharmacology.

[138]  A Hofman,et al.  Frequency and impact of neurologic diseases in the elderly of Europe: A collaborative study of population-based cohorts. , 2000, Neurology.

[139]  R. Uauy,et al.  The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations , 2008, Journal of perinatal medicine.

[140]  Shih-Yi Huang,et al.  The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: A preliminary randomized double-blind placebo-controlled study , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[141]  P. Rzehak,et al.  Evidence for an association between genetic variants of the fatty acid desaturase 1 fatty acid desaturase 2 (FADS1 FADS2) gene cluster and the fatty acid composition of erythrocyte membranes , 2008, British Journal of Nutrition.

[142]  R. Uauy,et al.  Long chain polyunsaturated fatty acids (LC‐PUFA) and perinatal development , 2001, Acta paediatrica.

[143]  W. Harris,et al.  n-3 Fatty acids and cardiovascular disease. , 2004, The American journal of clinical nutrition.

[144]  Sang Beom Jun,et al.  Docosahexaenoic acid promotes hippocampal neuronal development and synaptic function , 2009, Journal of neurochemistry.

[145]  P. Barberger‐Gateau,et al.  Cognitive function after supplementation with B vitamins and long-chain omega-3 fatty acids: ancillary findings from the SU.FOL.OM3 randomized trial. , 2011, The American journal of clinical nutrition.

[146]  D. Pella,et al.  Metabolic syndrome: a brain disease. , 2012, Canadian journal of physiology and pharmacology.

[147]  G. Schmitz,et al.  The opposing effects of n-3 and n-6 fatty acids. , 2008, Progress in lipid research.

[148]  M. Stafford,et al.  Efficacy and safety of long-chain polyunsaturated fatty acid supplementation of infant-formula milk: a randomised trial , 1999, The Lancet.

[149]  Y. Stern,et al.  Mediterranean diet, inflammatory and metabolic biomarkers, and risk of Alzheimer's disease. , 2010, Journal of Alzheimer's disease : JAD.

[150]  H. Perera,et al.  Combined ω3 and ω6 Supplementation in Children With Attention-Deficit Hyperactivity Disorder (ADHD) Refractory to Methylphenidate Treatment , 2012, Journal of child neurology.

[151]  K. Yurko-Mauro.  Cognitive and cardiovascular benefits of docosahexaenoic acid in aging and cognitive decline. , 2010, Current Alzheimer research.

[152]  A. Simopoulos.  Genetic variants in the metabolism of omega-6 and omega-3 fatty acids: their role in the determination of nutritional requirements and chronic disease risk , 2010, Experimental biology and medicine.

[153]  L. Downey,et al.  The effects of 90-day supplementation with the Omega-3 essential fatty acid docosahexaenoic acid (DHA) on cognitive function and visual acuity in a healthy aging population , 2012, Neurobiology of Aging.

[154]  E. Masliah,et al.  An antibody against phosphorylated neurofilaments identifies a subset of damaged association axons in Alzheimer's disease. , 1993, The American journal of pathology.

[155]  J. Buckley,et al.  Eicosapentaenoic and docosahexaenoic acids, cognition, and behavior in children with attention-deficit/hyperactivity disorder: a randomized controlled trial. , 2012, Nutrition.

[156]  A. Blackwell,et al.  Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline , 2010, Alzheimer's & Dementia.

[157]  G. Hacioglu,et al.  The effects of docosahexaenoic acid on glial derived neurotrophic factor and neurturin in bilateral rat model of Parkinson's disease. , 2010, Folia histochemica et cytobiologica.

[158]  R. Weisinger,et al.  The role of eicosanoids in the brain. , 2008, Asia Pacific journal of clinical nutrition.

[159]  R. Mayeux,et al.  Metabolic syndrome and dementia risk in a multiethnic elderly cohort , 2007, Journal of the Neurological Sciences.

[160]  F. Calon.  Omega-3 polyunsaturated fatty acids in Alzheimer's disease: key questions and partial answers. , 2011, Current Alzheimer research.

[161]  Mehmet Cansev,et al.  Uridine and cytidine in the brain: Their transport and utilization , 2006, Brain Research Reviews.

[162]  J. Bourre,et al.  Dietary omega-3 fatty acids for women. , 2007, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[163]  N. Salem,et al.  Behavioral Deficits Associated with Dietary Induction of Decreased Brain Docosahexaenoic Acid Concentration , 2000, Journal of neurochemistry.

[164]  T. Latronico,et al.  Developmental omega-3 supplementation improves motor skills in juvenile-adult rats , 2009, International Journal of Developmental Neuroscience.

[165]  A. Simopoulos.  The omega-6/omega-3 fatty acid ratio, genetic variation, and cardiovascular disease. , 2008, Asia Pacific journal of clinical nutrition.

[166]  David R. Brown.  Role of Microglia in Age-Related Changes to the Nervous System , 2009, TheScientificWorldJournal.

[167]  J. Nutt,et al.  Parkinson's disease , 2004, The Lancet.

[168]  P. Rhodes,et al.  Effect of Fish Oil Supplementation on the n-3 Fatty Acid Content of Red Blood Cell Membranes in Preterm Infants , 1987, Pediatric Research.

[169]  K. Simmer.  Long-chain polyunsaturated fatty acid supplementation in infants born at term. , 2000, The Cochrane database of systematic reviews.

[170]  H. Bremer,et al.  Effects of dietary long-chain polyunsaturated fatty acids on the essential fatty acid status of premature infants , 2004, European Journal of Pediatrics.

[171]  C. Transler,et al.  Effects of n-3 long chain polyunsaturated fatty acid supplementation on visual and cognitive development throughout childhood: a review of human studies. , 2007, Prostaglandins, leukotrienes, and essential fatty acids.

[172]  J. Neu.  Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow-up study of a randomized controlled trial , 2010 .

[173]  K. Radeborg,et al.  Effects of supplementation with n-3 polyunsaturated fatty acids on cognitive performance and cardiometabolic risk markers in healthy 51 to 72 years old subjects: a randomized controlled cross-over study , 2012, Nutrition Journal.

[174]  E. Masliah,et al.  Synaptic remodeling during aging and in Alzheimer's disease. , 2006, Journal of Alzheimer's disease : JAD.

[175]  L. Palmer,et al.  Common genetic variants of the FADS1 FADS2 gene cluster and their reconstructed haplotypes are associated with the fatty acid composition in phospholipids. , 2006, Human molecular genetics.

[176]  Takashi Morihara,et al.  Docosahexaenoic Acid Protects from Dendritic Pathology in an Alzheimer's Disease Mouse Model , 2004, Neuron.

[177]  E. Birch,et al.  A randomized controlled trial of early dietary supply of long‐chain polyunsaturated fatty acids and mental development in term infants , 2000, Developmental medicine and child neurology.

[178]  R. Wurtman,et al.  Effect of oral CDP-choline on plasma choline and uridine levels in humans. , 2000, Biochemical pharmacology.

[179]  David A Wolk,et al.  Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias. , 2012, Brain : a journal of neurology.

[180]  Noor Aini Mohd Yusoff,et al.  Docosahexaenoic acid-concentrated fish oil supplementation in subjects with mild cognitive impairment (MCI): a 12-month randomised, double-blind, placebo-controlled trial , 2012, Psychopharmacology.

[181]  H. Jing,et al.  Early Infant Diet and the Omega 3 Fatty Acid DHA: Effects on Resting Cardiovascular Activity and Behavioral Development During the First Half-Year of Life , 2009, Developmental neuropsychology.

[182]  P. Calder,et al.  Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial , 2003, The Lancet.

[183]  P. Scheltens,et al.  Efficacy of a medical food in mild Alzheimer's disease: A randomized, controlled trial , 2010, Alzheimer's & Dementia.

[184]  E. Birch,et al.  The DIAMOND (DHA Intake And Measurement Of Neural Development) Study: a double-masked, randomized controlled clinical trial of the maturation of infant visual acuity as a function of the dietary level of docosahexaenoic acid. , 2010, The American journal of clinical nutrition.

[185]  P. Sastry,et al.  Lipids of nervous tissue: composition and metabolism. , 1985, Progress in lipid research.

[186]  R. Gibson,et al.  Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. , 2010, JAMA.

[187]  H. Tojo,et al.  Dietary α-linolenate/linoleate balance influences learning and memory in the senescence-accelerated mouse (SAM) , 1995, Brain Research.

[188]  C. Johanson,et al.  Apolipoprotein E, Amyloid-&bgr;, and Blood-Brain Barrier Permeability in Alzheimer Disease , 2008, Journal of neuropathology and experimental neurology.

[189]  C. Qiu.  Preventing Alzheimer's disease by targeting vascular risk factors: hope and gap. , 2012, Journal of Alzheimer's disease : JAD.

[190]  G. Cole,et al.  Docosahexaenoic Acid Protects from Amyloid and Dendritic Pathology in an Alzheimer's Disease Mouse Model , 2006, Nutrition and health.

[191]  R. Leighty,et al.  A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer’s transgenic mice , 2007, Neuroscience.

[192]  T. Hamazaki,et al.  Effect of docosahexaenoic acid-containing food administration on symptoms of attention-deficit/hyperactivity disorder — a placebo-controlled double-blind study , 2004, European Journal of Clinical Nutrition.

[193]  T. Mori,et al.  Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans. , 1999, Hypertension.

[194]  Lars-Olof Wahlund,et al.  Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. , 2006, Archives of neurology.

[195]  R. Munhoz,et al.  Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation. , 2008, Journal of affective disorders.

[196]  M. Feki,et al.  Polyunsaturated fatty acids deficits are associated with psychotic state and negative symptoms in patients with schizophrenia. , 2010, Prostaglandins, leukotrienes, and essential fatty acids.

[197]  C. Jones,et al.  Dietary supplementation with marine omega-3 fatty acids improve systemic large artery endothelial function in subjects with hypercholesterolemia. , 2000, Journal of the American College of Cardiology.

[198]  S. Prescott,et al.  Cognitive assessment of children at age 2½ years after maternal fish oil supplementation in pregnancy: a randomised controlled trial , 2006, Archives of Disease in Childhood Fetal and Neonatal Edition.

[199]  L. Puskás,et al.  Effects of dietary omega-3 polyunsaturated fatty acids on brain gene expression. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[200]  Jens C. Pruessner,et al.  Regional Frontal Cortical Volumes Decrease Differentially in Aging: An MRI Study to Compare Volumetric Approaches and Voxel-Based Morphometry , 2002, NeuroImage.

[201]  P. Gisquet-Verrier,et al.  Dietary n-3 polyunsaturated fatty acid deprivation together with early maternal separation increases anxiety and vulnerability to stress in adult rats. , 2011, Prostaglandins, leukotrienes, and essential fatty acids.

[202]  M. Behbehani,et al.  Stimulation of the rat subthalamic nucleus is neuroprotective following significant nigral dopamine neuron loss , 2010, Neurobiology of Disease.

[203]  C. L. Jensen,et al.  A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder. , 2001, The Journal of pediatrics.

[204]  T. Terano,et al.  Docosahexaenoic acid supplementation improves the moderately severe dementia from thrombotic cerebrovascular diseases , 2007, Lipids.

[205]  W. Harris,et al.  Cardiovascular risk and the omega-3 index , 2007, Journal of cardiovascular medicine.

[206]  D. Grobbee,et al.  Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials , 2002, Journal of hypertension.

[207]  M. Tierney,et al.  Fatty acid analysis of blood plasma of patients with alzheimer's disease, other types of dementia, and cognitive impairment , 2000, Lipids.

[208]  A. Sandler.  Double-blind, randomized trial of long-chain polyunsaturated fatty acid supplementation in formula fed to preterm infants. , 2003 .

[209]  R. P. Ross,et al.  Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids. , 2010, Nutrition reviews.

[210]  D. Mozaffarian,et al.  (n-3) fatty acids and cardiovascular health: are effects of EPA and DHA shared or complementary? , 2012, The Journal of nutrition.

[211]  G. Mariani,et al.  Fatty acid facts, Part IV: docosahexaenoic acid and Alzheimer's disease. A story of mice, men and fish. , 2009, Drug News and Perspectives.

[212]  D. Kromhout,et al.  Mediterranean Style Diet and 12-Year Incidence of Cardiovascular Diseases: The EPIC-NL Cohort Study , 2012, PloS one.

[213]  L. Smithers,et al.  Higher dose of docosahexaenoic acid in the neonatal period improves visual acuity of preterm infants: results of a randomized controlled trial. , 2008, The American journal of clinical nutrition.

[214]  J. Janowsky,et al.  Growth and development in preterm infants fed long-chain polyunsaturated fatty acids: a prospective, randomized controlled trial. , 2001, Pediatrics.

[215]  J. Manson,et al.  Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. , 2002, JAMA.

[216]  D. Mostofsky,et al.  Fatty acids : physiological and behavioral functions , 2001 .

[217]  F. Calon,et al.  DHA Improves Cognition and Prevents Dysfunction of Entorhinal Cortex Neurons in 3xTg-AD Mice , 2011, PloS one.

[218]  L. Smithers,et al.  Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. , 2011, The American journal of clinical nutrition.

[219]  Yaakov Stern,et al.  Mediterranean diet and Alzheimer disease mortality , 2007, Neurology.

[220]  M. Fitzgerald,et al.  Clinical neuroanatomy and related neuroscience , 2002 .

[221]  F. Cicchetti,et al.  Transgenic conversion of omega-6 into omega-3 fatty acids in a mouse model of Parkinson's disease , 2011, Journal of Lipid Research.

[222]  M. Koshiba,et al.  Effects of Large Doses of Arachidonic Acid Added to Docosahexaenoic Acid on Social Impairment in Individuals With Autism Spectrum Disorders: A Double-Blind, Placebo-Controlled, Randomized Trial , 2012, Journal of clinical psychopharmacology.

[223]  Marcus Richards,et al.  Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: a randomized, double-blind, controlled trial. , 2010, The American journal of clinical nutrition.

[224]  D. Horrobin,et al.  Ethyl-EPA in Alzheimer's disease--a pilot study. , 2004, Prostaglandins, leukotrienes, and essential fatty acids.

[225]  G. Patton,et al.  Low serum docosahexaenoic acid is a significant risk factor for alzheimer’s dementia , 2007, Lipids.

[226]  E. Hirsch,et al.  Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra. , 1999, Neuroreport.

[227]  R. Wurtman.  Synapse formation and cognitive brain development: effect of docosahexaenoic acid and other dietary constituents. , 2008, Metabolism: clinical and experimental.

[228]  P. Sorgi,et al.  Effects of an open-label pilot study with high-dose EPA/DHA concentrates on plasma phospholipids and behavior in children with attention deficit hyperactivity disorder , 2007, Nutrition journal.

[229]  Noriyuki Matsukawa,et al.  Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction , 2006, Neuroscience Research.

[230]  D. McCulloch,et al.  Maternal docosahexaenoic acid supplementation during pregnancy and visual evoked potential development in term infants: a double blind, prospective, randomised trial , 2003, Archives of disease in childhood. Fetal and neonatal edition.

[231]  J. Takahashi,et al.  Therapeutic application of stem cell technology toward the treatment of Parkinson's disease. , 2013, Biological & pharmaceutical bulletin.

[232]  Laura Moretti,et al.  Cognitive decline in older adults with a history of traumatic brain injury , 2012, The Lancet Neurology.

[233]  Virginie Rondeau,et al.  Adherence to a Mediterranean diet, cognitive decline, and risk of dementia. , 2009, JAMA.

[234]  R. Martins,et al.  The effect of APOE genotype on brain levels of oxysterols in young and old human APOE ε2, ε3 and ε4 knock-in mice , 2010, Neuroscience.

[235]  C. Klier,et al.  Omega-3 Fatty Acids Supplementation in Children with Autism: A Double-blind Randomized, Placebo-controlled Pilot Study , 2007, Biological Psychiatry.

[236]  M. Haan,et al.  Can dementia be prevented? Brain aging in a population-based context. , 2004, Annual review of public health.

[237]  R. Lamuela-Raventós,et al.  Frequency of nut consumption and mortality risk in the PREDIMED nutrition intervention trial , 2013, BMC Medicine.

[238]  S. Rapoport,et al.  n-3 Polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism , 2007, Molecular Psychiatry.

[239]  D. Hoffman,et al.  Toward optimizing vision and cognition in term infants by dietary docosahexaenoic and arachidonic acid supplementation: a review of randomized controlled trials. , 2009, Prostaglandins, leukotrienes, and essential fatty acids.

[240]  J. Palmblad,et al.  Are omega-3 fatty acids options for prevention and treatment of cognitive decline and dementia? , 2010, Current opinion in clinical nutrition and metabolic care.

[241]  M. Lavialle,et al.  Effect of a diet-induced n-3 PUFA depletion on cholinergic parameters in the rat hippocampus Published, JLR Papers in Press, May 16, 2003. DOI 10.1194/jlr.M300079-JLR200 , 2003, Journal of Lipid Research.

[242]  S. Carlson,et al.  Decreased brain docosahexaenoic acid during development alters dopamine-related behaviors in adult rats that are differentially affected by dietary remediation , 2003, Behavioural Brain Research.

[243]  G. Pascal,et al.  Alterations in the Fatty Acid Composition of Rat Brain Cells (Neurons, Astrocytes, and Oligodendrocytes) and of Subcellular Fractions (Myelin and Synaptosomes) Induced by a Diet Devoid of n‐3 Fatty Acids , 1984, Journal of neurochemistry.

[244]  N. Salem,et al.  Recovery of brain docosahexaenoate leads to recovery of spatial task performance , 2003, Journal of neurochemistry.